Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.47 | 15322242 14514962 11752688 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
4.01 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.34 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.47 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.51 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
3.00 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.06 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.06 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.12 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.79 | 16705839 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.68 | 19215824 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.56 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.46 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.46 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.21 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.24 | 15340226 8697196 16354765 15668235 12621046 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.38 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.11 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.43 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.27 | 20055451 15322242 10048152 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.58 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.74 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.00 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.00 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
3.05 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.80 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.62 | 18230668 15322242 16714409 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.84 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.42 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.28 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
4.02 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
10.42 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
10.42 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.85 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.32 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.74 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.51 | 10048152 11294989 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.05 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.76 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.45 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.77 | 16354765 18606429 8697196 15340226 16959395 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.35 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.35 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.45 | 17581917 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
2.03 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.76 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.16 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.54 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.44 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
8.44 | 12371664 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.24 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.43 | 17236224 18454857 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.43 | 18460780 18206229 19387464 18704418 19010910 17679729 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
6.19 | 18055864 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.25 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.78 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.78 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.50 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.50 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.69 | 19470736 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.28 | 16505122 17785578 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.51 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.62 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.58 | 19010910 19157545 18608210 16882708 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.34 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.49 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
decitabine |
2.87 | 19470736 17925555 19116145 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.16 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.65 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.72 | 14600291 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.83 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.74 | 19259094 19331143 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.87 | 19294695 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.97 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
4.07 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.59 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.82 | 11896295 11399792 11222880 11118676 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.29 | 17616702 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.33 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.35 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.87 | 19155313 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.79 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.20 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.62 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.63 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.59 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.59 | 19087683 17616700 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.95 | 10091137 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.64 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.71 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.32 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.97 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.16 | 17120751 |